Spectre of widespread breast explantations returns with PIP recall
This article was originally published in Clinica
Executive Summary
The scale of the potential impact of French investigations into breast implants manufactured by Poly Implant Prothèse (PIP) has begun to emerge, as alarm over the potential need to explant tens of thousands of women is spreading internationally.
You may also be interested in...
Medtechs Must Act Fast On New EU Regulations Or Face Gridlock
Following the recent vote in the European Parliament, the EU has finally adopted the Medical Device and IVD Regulations that were proposed back in September 2012. The texts, vastly longer and more complex than the three directives they are replacing, will establish a tougher regulatory code for the next decade or more, but where are the likely pressure points for industry and how can manufacturers prepare?
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.